Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study

PURPOSE: To describe patients’ perspectives on the use of and potential challenges and barriers with adherence/persistence to cyclin-dependent kinase 4 and 6 inhibitors (CDK4&6i’s) to treat metastatic breast cancer (MBC). METHODS: This qualitative study consisted of 60-minute semi-structured tel...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenson, Judith J, Gable, Jonathon Colby, Zincavage, Rebekah, Price, Gregory L, Churchill, Collin, Zhu, Emily, Stenger, Keri, Singhal, Mukul, Nepal, Bal, Grabner, Michael, Fisch, Michael J, Debono, David, Geschwender, Amy R, Cuyun Carter, Gebra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573215/
https://www.ncbi.nlm.nih.gov/pubmed/34764640
http://dx.doi.org/10.2147/PPA.S319239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573215/
https://www.ncbi.nlm.nih.gov/pubmed/34764640
http://dx.doi.org/10.2147/PPA.S319239

Ejemplares similares